Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems

被引:52
作者
Igartua, M [1 ]
Hernandez, RM [1 ]
Esquisabel, A [1 ]
Gascon, AR [1 ]
Calvo, MB [1 ]
Pedraz, JL [1 ]
机构
[1] UNIV BASQUE COUNTRY,FAC PHARM,LAB PHARM & PHARMACEUT TECHNOL,VITORIA 01006,SPAIN
关键词
poly(D; L-lactide-co-glycolide); bovine serum albumin; microsphere; release kinetics;
D O I
10.3109/02652049709051138
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Poly(D,L-lactide-co-glycolide) microspheres containing BSA were prepared by a modified solvent evaporation method using a double emulsion. These microspheres were characterized for size, morphology, surface adsorbed protein, encapsulation efficiency and release kinetics. The influence of two formulation variables (the procedure to obtain the first emulsion and the lyophilization of the microspheres once obtained) on the physical characteristics and release behaviour of the microspheres was also investigated. Sonicated microspheres were smooth and spherical, with a mean particle size of 20 mu m and an encapsulation efficiency of 81%. When the first emulsion was prepared by vortex mixing the particles were irregular and porous, with a mean size of 31 mu m and a lower encapsulation efficiency (56%). The sonication allows a more homogeneous emulsion as well as a lower percentage of albumin adsorbed on the surface. The in vitro release profile was described as a biexponential process with an initial burst effect due to the release of the protein adsorbed on the microsphere surface and a second sustained release phase due to protein diffusion through the channels or pores formed in the polymer coat. The release of BSA was dependent on the preparation method. The greatest burst release was found for microspheres formulated using the vortex mixer, 58% of the encapsulated protein was released during the first 24 h, whereas sonicated microspheres released 32.2%. This burst effect could be reduced by lyophilizing the microspheres following their preparation. The amount of protein released decreased to 28.3% and 51.6% in sonicated and non-sonicated microspheres respectively, when they were lyophilized.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 18 条
[11]   CONTROLLED-RELEASE MICROPARTICLES FOR ORAL IMMUNIZATION [J].
OHAGAN, DT ;
RAHMAN, D ;
JEFFERY, H ;
SHARIF, S ;
CHALLACOMBE, SJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 108 (02) :133-139
[12]  
RYAN B.F., 1985, MINITAB HDB
[13]   BIODEGRADABLE MICROPARTICLES AS A DELIVERY SYSTEM FOR THE ALLERGENS OF DERMATOPHAGOIDES-PTERONYSSINUS (HOUSE-DUST MITE) .1. PREPARATION AND CHARACTERIZATION OF MICROPARTICLES [J].
SHARIF, S ;
WHEELER, AW ;
OHAGAN, DT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 119 (02) :239-246
[14]   MEASUREMENT OF PROTEIN USING BICINCHONINIC ACID [J].
SMITH, PK ;
KROHN, RI ;
HERMANSON, GT ;
MALLIA, AK ;
GARTNER, FH ;
PROVENZANO, MD ;
FUJIMOTO, EK ;
GOEKE, NM ;
OLSON, BJ ;
KLENK, DC .
ANALYTICAL BIOCHEMISTRY, 1985, 150 (01) :76-85
[15]   DOSE AND LOAD STUDIES FOR SUBCUTANEOUS AND ORAL DELIVERY OF POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES CONTAINING OVALBUMIN [J].
UCHIDA, T ;
MARTIN, S ;
FOSTER, TP ;
WARDLEY, RC ;
GRIMM, S .
PHARMACEUTICAL RESEARCH, 1994, 11 (07) :1009-1015
[16]   INFLUENCE OF FORMULATION METHODS ON THE INVITRO CONTROLLED RELEASE OF PROTEIN FROM POLY(ESTER) MICROSPHERES [J].
WANG, HT ;
SCHMITT, E ;
FLANAGAN, DR ;
LINHARDT, RJ .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (01) :23-31
[17]   DRUG RELEASE FROM MICRODISPERSE SYSTEMS - A CRITICAL-REVIEW [J].
WASHINGTON, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 58 (01) :1-12
[18]  
WEINER DL, 1986, METHOD FIND EXP CLIN, V8, P625